MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
PR Newswire

News of the day

Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor

13th November 2009 INDIANAPOLIS, November 13 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Steven M. Paul, M.D., executive vice president, science and technology, and president, Lilly Research Laboratories, will retire from Lilly effective February 28, 2010. Lilly has also announced that Jan M. Lundberg, Ph.D., executive vice president and head of global discovery research, AstraZeneca, is to become his successor. Paul is committed to working closely with Lundberg to ensure a successful... more

William Cork Joins Fenwal as Chief Technology Officer

10th November 2009 LAKE ZURICH, Illinois, November 10 /PRNewswire/ -- Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today William H. Cork has joined the company as senior vice president and chief technology officer. Mr. Cork, 50, will lead Fenwal's research and development, regulatory and clinical affairs teams, reporting to Ron K. Labrum, Fenwal's president and chief executive officer. Mr. Cork joins Fenwal from... more

Allied World's Eugene Raitt Elected 2010 Chairman of the Board for the Direct Marketing Association

4th November 2009 PEMBROKE, Bermuda, November 4 /PRNewswire/ -- Allied World Assurance Company, Ltd, a member company of Allied World Assurance Company Holdings, Ltd (NYSE: AWH) today announced that Eugene Raitt, Senior Vice President, Accident & Health and Chief Marketing Officer, Asia, has been elected Chairman of the Board for the Direct Marketing Association for 2010. Mr. Raitt served as Board Vice Chairman in 2009. The Direct Marketing Association (DMA) is a global trade association, with over 3,100... more
Personnel Announcements RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
 

Category

To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Browse by category

More recent news

New Shire Board Member
2nd November 2009 DUBLIN, Ireland, November 2 /PRNewswire/ -- The Board of Directors of Shire plc (LSE: SHP, NASDAQ: SHPGY) announces that Mr David Stout joined the Board as a Non Executive Director with effect from...

Raptor Pharmaceutical Expands Board of Directors
1st October 2009 NOVATO, California, October 1 /PRNewswire/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD), today announced the appointment of Llew Keltner, M.D., Ph.D., to the Company's...

Stephen W. Borron, M.D., Named Medical Editor-In-Chief of ToxED
28th September 2009 PHILADELPHIA, September 28 /PRNewswire/ -- Elsevier, the leading publisher of scientific, technical and medical information announced today that, the Stephen W. Borron, M.D., has been named Medical...

AMT Appoints New Chief Executive Officer
24th September 2009 AMSTERDAM, September 24 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in human gene therapy, announced today the appointment of Jorn Aldag as its new Chief Executive...

New Appointments at London Genetics to Drive Strategy Forward
18th September 2009 LONDON, September 18 /PRNewswire/ -- London Genetics Limited, which expedites pharmacogenetic partnerships between the biopharmaceutical industry and London-based centres of excellence in genetics...

NeuroFocus Names Dr. Steven Miller to Head Global Neurological Laboratory Operations
18th September 2009 BERKELEY, California, September 18 /PRNewswire/ -- NeuroFocus, the world's leading neuromarketing company, announced that it has named Dr. Steven L. Miller to lead its neurological testing...

New Nominee for WHO Regional Director for Europe
16th September 2009 COPENHAGEN, September 16 /PRNewswire/ -- Zsuzsanna Jakab has been nominated as the new WHO Regional Director for Europe by the WHO European Region's governing body in Copenhagen. Mrs Jakab, the first...

New Collaborations and Breakthrough Advancements in RNA-Based Drug Development Programs Lead Santaris Pharma A/S to Establish US Operations
16th September 2009 HOERSHOLM, Denmark and SAN DIEGO, California, September 16 /PRNewswire/ -- Santaris Pharma A/S, a privately-held biopharmaceutical company focused on developing RNA-based drugs targeted to...

Linda Dyson Joins Cohn & Wolfe as Global Healthcare Practice Leader
10th September 2009 NEW YORK, September 10 /PRNewswire/ -- Cohn & Wolfe, a leading global public relations agency, today announced that Linda Dyson has joined the firm as Executive Vice President and Global Healthcare...

PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head, Product & Portfolio Strategy
10th September 2009 OXFORD, England, September 10 /PRNewswire/ -- PharmaVentures announced today the appointment of Nikki Watkins as Head of the Product & Portfolio Strategy Practice of Corporate Advisory, leading...

/C O R R E C T I O N -- Clinical Therapeutics/
10th September 2009 BRIDGEWATER, New Jersey, September 9 /PRNewswire/ -- In the news release, "Clinical Therapeutics Announces the Addition of Michael G. Spigarelli, MD, PhD, as Editor for a Refocused Pediatric,...

Clinical Therapeutics Announces the Addition of Michael G. Spigarelli, MD, PhD, as Editor for a Refocused Pediatric, Adolescent, & Maternal Therapeutics Section
9th September 2009 BRIDGEWATER, England, September 9 /PRNewswire/ -- Clinical Therapeutics,( http://www.clinicaltherapeutics.com/) the world's premier, rapid-publication journal, is proud to announce the addition...

New Chief Executive Officer and Vice President Commercial Operations USA at the Helsinn Group's American subsidiary, Helsinn Therapeutics (U.S.) Inc.
9th September 2009 LUGANO, Switzerland, September 9 /PRNewswire/ -- As part of the Helsinn Group's development strategy, William Mann, PhD, has been appointed as new CEO in the American subsidiary, Helsinn Therapeutics...

Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research & Development
1st September 2009 COPENHAGEN and OSLO, September 1 /PRNewswire/ -- Affitech A/S, (Nasdaq OMX: AFFI), the antibody medicines company, today announced that it has appointed two experienced biotech executives to head its...

Aircraft Reports Material Expansion and Staff Increase
1st September 2009 EDINBURGH, Scotland, September 1 /PRNewswire/ -- Aircraft Medical (Aircraft), the UK medical devices company, announces that it has added 25 new staff to its R&D, business development and sales teams...

Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed
31st August 2009 BOZEN, Italy, August 31 /PRNewswire/ -- Health Robotics today announced that National Taiwan University Hospital (NTUH) has purchased and agreed to immediately install its flagship CytoCare Robot...

Charlie Buckwell Appointed Medical Communications Head, Further Advancing McCann Healthcare Worldwide's Global Capabilities
21st August 2009 NEW YORK, August 21 /PRNewswire/ -- McCann Healthcare Worldwide is re-aligning and expanding its medical communications businesses, to build a dedicated, unified and empowered medical communications...

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us